|
RANBP6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.35940000000202E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.159380E-03 |
| Normal-vs-Stage2 |
7.501600E-03 |
| Normal-vs-Stage3 |
4.32670000000135E-05 |
| Normal-vs-Stage4 |
7.87720000006153E-07 |
| Stage1-vs-Stage2 |
7.606800E-01 |
| Stage1-vs-Stage3 |
1.274010E-01 |
| Stage1-vs-Stage4 |
5.916500E-03 |
| Stage2-vs-Stage3 |
4.653000E-01 |
| Stage2-vs-Stage4 |
1.070820E-01 |
| Stage3-vs-Stage4 |
2.412000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.30439999999921E-05 |
| Normal-vs-AfricanAmerican |
4.155800E-02 |
| Normal-vs-Asian |
3.090000E-02 |
| Caucasian-vs-AfricanAmerican |
5.512600E-01 |
| Caucasian-vs-Asian |
1.927570E-01 |
| AfricanAmerican-vs-Asian |
7.401600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.9591000000041E-06 |
| Normal-vs-Female |
6.208400E-04 |
| Male-vs-Female |
5.829600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.658700E-03 |
| Normal-vs-Age(41-60Yrs) |
7.95740000000267E-05 |
| Normal-vs-Age(61-80Yrs) |
5.91759999999386E-05 |
| Normal-vs-Age(81-100Yrs) |
1.062600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.754850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.094990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.196800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.254200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.396000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.030000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.147800E-01 |
| Classical-VS-Follicular |
2.802300E-03 |
| Classical-VS-Other |
7.773800E-02 |
| Classical-VS-Normal |
3.902600E-03 |
| Tall-VS-Follicular |
5.152000E-01 |
| Tall-VS-Other |
2.379400E-01 |
| Tall-VS-Normal |
2.062000E-03 |
| Follicular-VS-Other |
4.762800E-01 |
| Follicular-VS-Normal |
1.65212999999609E-05 |
| Other-VS-Normal |
4.779200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.67880000000143E-05 |
| Normal-vs-N1 |
1.74276000000084E-05 |
| N0-vs-N1 |
1.390810E-01 |
|
|
